FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
WEDNESDAY, May 31, 2023 – Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they’re getting the medication, the U.S. Food and Drug Administration warned Tuesday.
Shortages of the drug, commonly sold as...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Food and Drug Administration (FDA) | General Medicine | Warnings | Weight Loss